Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
BMS-275291. Bristol-Myers SquibbVassiliki Poulaki
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 3, 2006
Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurityNorbert Kociok, Tim U Krohne, Vassiliki Poulaki, et al.
Blood|March 6, 2002
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
The American Journal of Pathology|December 6, 2002
Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viabilityVassiliki Poulaki, Constantine S Mitsiades, Antonia M Joussen, et al.
Investigative Ophthalmology & Visual Science|June 26, 2009
Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathyEirini Iliaki, Vassiliki Poulaki, Nicholas Mitsiades, et al.
The American Journal of Pathology|July 28, 2004
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathyVassiliki Poulaki, Antonia M Joussen, Nicholas Mitsiades, et al.
The American Journal of Pathology|March 25, 2004
Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expressionVassiliki Poulaki, Nicholas Mitsiades, Friedrich E Kruse, et al.
Investigative Ophthalmology & Visual Science|September 28, 2007
The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitroVassiliki Poulaki, Constantine S Mitsiades, Vassiliki Kotoula, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2002
Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppressionAntonia M Joussen, Vassiliki Poulaki, Nicholas Mitsiades, et al.
Investigative Ophthalmology & Visual Science|August 11, 2011
Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapyNicholas Mitsiades, Sue Anne Chew, Bin He, et al.
Pageof 4